Mtor (mechanistic target of rapamycin kinase) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Mtor (mechanistic target of rapamycin kinase) Rattus norvegicus
Analyze
Symbol: Mtor
Name: mechanistic target of rapamycin kinase
RGD ID: 68371
Description: Enables several functions, including protein kinase binding activity; protein serine/threonine kinase activity; and translation regulator activity. Involved in several processes, including positive regulation of cell population proliferation; regulation of muscle adaptation; and regulation of protein metabolic process. Acts upstream of or within cell projection organization and negative regulation of cell size. Located in cytosol and nucleus. Part of TORC1 complex. Is active in glutamatergic synapse and postsynaptic cytosol. Colocalizes with dendrite and neuronal cell body. Used to study several diseases, including artery disease (multiple); brain disease (multiple); crescentic glomerulonephritis; kidney failure (multiple); and muscular atrophy. Biomarker of several diseases, including middle cerebral artery infarction; obesity; type 2 diabetes mellitus; ureteral obstruction; and vascular dementia. Human ortholog(s) of this gene implicated in autosomal dominant polycystic kidney disease; kidney angiomyolipoma; lung disease (multiple); prostate cancer; and type 2 diabetes mellitus. Orthologous to human MTOR (mechanistic target of rapamycin kinase); PARTICIPATES IN mTOR signaling pathway; interleukin-12 signaling pathway; interleukin-4 signaling pathway; INTERACTS WITH (+)-pilocarpine; (+)-taxifolin; (S)-nicotine.
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: FK506 binding protein 12-rapamycin associated protein 1; FK506-binding protein 12-rapamycin complex-associated protein 1; FKBP12-rapamycin complex-associated protein; Frap1; mammalian target of rapamycin; mechanistic target of rapamycin; mechanistic target of rapamycin (serine/threonine kinase); RAFT1; rapamycin and FKBP12 target-1 protein; rapamycin target protein 1; RAPT1; serine/threonine-protein kinase mTOR
RGD Orthologs
Human
Mouse
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
mRatBN7.25158,884,856 - 158,994,311 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl5158,884,804 - 158,994,311 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx5161,601,607 - 161,711,017 (+)NCBIRnor_SHR
UTH_Rnor_SHRSP_BbbUtx_1.05163,423,732 - 163,533,437 (+)NCBIRnor_SHRSP
UTH_Rnor_WKY_Bbb_1.05163,380,079 - 163,489,786 (+)NCBIRnor_WKY
Rnor_6.05165,263,813 - 165,373,967 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl5165,263,800 - 165,373,967 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.05168,920,414 - 169,030,568 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.45165,531,402 - 165,640,899 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.15165,541,594 - 165,651,087 (+)NCBI
Celera5157,161,454 - 157,270,899 (+)NCBICelera
Cytogenetic Map5q36NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View
acute kidney failure  (IMP)
adenocarcinoma  (ISO)
AIDS-Associated Nephropathy  (ISO)
autosomal dominant polycystic kidney disease  (ISO)
autosomal recessive polycystic kidney disease  (IDA)
Breast Neoplasms  (ISO)
Burns  (IDA)
Cardiomegaly  (IMP)
CEBALID Syndrome  (ISO)
Cerebral Hemorrhage  (IMP)
chondrosarcoma  (IMP)
Chronic Allograft Dysfunction  (IDA)
colon cancer  (IEP)
Colonic Neoplasms  (ISO)
Colorectal Neoplasms  (ISO)
complex cortical dysplasia with other brain malformations  (ISO)
congestive heart failure  (ISO)
crescentic glomerulonephritis  (IMP)
Diabetes Mellitus, New-Onset after Transplantation  (ISO)
Diabetic Nephropathies  (IDA,ISO)
Drug-Induced Dyskinesia  (IMP)
end stage renal disease  (IMP)
endocrine system disease  (ISO)
epilepsy  (ISO)
exocrine pancreatic insufficiency  (ISO)
Experimental Arthritis  (IEP)
Experimental Diabetes Mellitus  (IDA)
Experimental Liver Cirrhosis  (IEP)
Experimental Mammary Neoplasms  (IMP)
Familial Atrial Fibrillation 6  (ISO)
Focal Cortical Dysplasia of Taylor  (ISO)
gastric adenocarcinoma  (ISO)
genetic disease  (ISO)
glioblastoma  (ISO)
Hemimegalencephaly  (ISO)
Hemorrhagic Shock  (IDA)
hepatocellular carcinoma  (ISO)
Hepatomegaly  (ISO)
high grade glioma  (ISO)
Hyperalgesia  (IMP)
hypertension  (IDA,ISO)
Hypertriglyceridemia  (IMP)
idiopathic interstitial pneumonia  (ISO)
immunodeficiency 14  (ISO)
Inflammation  (IMP)
intellectual disability  (ISO)
interstitial cystitis  (ISO)
kidney angiomyolipoma  (ISO)
Left Ventricular Hypertrophy  (IDA,ISO)
Lung Injury  (ISO)
Lung Neoplasms  (ISO)
lung non-small cell carcinoma  (ISO)
lung small cell carcinoma  (ISO)
lupus nephritis  (ISO)
Lymphatic Metastasis  (ISO)
Macrocephaly  (ISO)
mantle cell lymphoma  (ISO)
melanoma  (ISO)
Mesothelioma  (ISO)
middle cerebral artery infarction  (IDA,IEP)
muscular atrophy  (IMP)
Muscular Dystrophy, Animal  (ISO)
myocardial infarction  (IDA)
Neoplasm Metastasis  (IMP)
nephritis  (ISO)
Neurodevelopmental Disorders  (ISO)
obesity  (IEP)
osteoarthritis  (ISO)
Ovarian Neoplasms  (ISO)
pancreatic cancer  (IMP)
pancreatic carcinoma  (ISO)
papillary renal cell carcinoma  (ISO)
Parkinsonism  (ISO)
Peroxisome Biogenesis Disorder, Complementation Group K  (ISO)
polycystic kidney disease  (IEP)
portal hypertension  (IMP)
prostate cancer  (ISO)
Prostatic Neoplasms  (ISO)
pulmonary fibrosis  (ISO)
pulmonary hypertension  (IMP)
renal carcinoma  (ISO)
renal cell carcinoma  (ISO)
Renal Cell Carcinoma 1  (ISO)
Retinal Neovascularization  (ISO)
Right Ventricular Hypertrophy  (IMP)
schizophrenia  (IMP,ISO)
sciatic neuropathy  (IMP)
Sepsis  (IDA)
skin melanoma  (ISO)
small cell carcinoma  (ISO)
Smith-Kingsmore Syndrome  (ISO)
Spinal Cord Injuries  (IMP)
Sporadic Papillary Renal Cell Carcinoma  (ISO)
status epilepticus  (IDA,IMP)
T-cell acute lymphoblastic leukemia  (ISO)
temporal lobe epilepsy  (IMP)
Temporomandibular Joint Disorders  (IDA)
toxic encephalopathy  (ISO)
transient cerebral ischemia  (IEP)
transitional cell carcinoma  (ISO)
type 2 diabetes mellitus  (IEP,ISO)
ureteral obstruction  (IEP)
urinary bladder cancer  (ISO)
uterine cancer  (ISO)
Uterine Cervical Neoplasms  (ISO)
vascular dementia  (IEP)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-pilocarpine  (EXP)
(+)-taxifolin  (EXP)
(+)-Tetrandrine  (ISO)
(-)-alpha-phellandrene  (ISO)
(-)-Arctigenin  (ISO)
(20S)-ginsenoside Rh2  (ISO)
(S)-colchicine  (ISO)
(S)-nicotine  (EXP,ISO)
1,1'-azobis(N,N-dimethylformamide)  (ISO)
1,1-dichloroethene  (ISO)
1,2-dimethylhydrazine  (EXP)
1,3-dichloropropan-2-ol  (ISO)
1,4-benzoquinone  (ISO)
1,4-phenylenediamine  (ISO)
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine  (ISO)
1-octadec-9-enoylglycero-3-phosphate  (EXP)
15-deoxy-Delta(12,14)-prostaglandin J2  (ISO)
17alpha-ethynylestradiol  (ISO)
17beta-estradiol  (EXP,ISO)
2,2',4,4'-Tetrabromodiphenyl ether  (ISO)
2,2',5,5'-tetrachlorobiphenyl  (EXP,ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,4,6-tribromophenol  (ISO)
2,4,6-trinitrobenzenesulfonic acid  (EXP)
2,4-dinitrotoluene  (EXP)
2,6-dinitrotoluene  (EXP)
2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile  (EXP)
2-chloroethanol  (ISO)
2-deoxy-D-glucose  (ISO)
20-hydroxyecdysone  (ISO)
3,3',5,5'-tetrabromobisphenol A  (ISO)
3,3',5-triiodo-L-thyronine  (ISO)
3-bromopyruvic acid  (ISO)
3-chloropropane-1,2-diol  (ISO)
3-methyladenine  (EXP,ISO)
4'-epidoxorubicin  (EXP)
4,4'-sulfonyldiphenol  (ISO)
4-hydroxynon-2-enal  (ISO)
4-nonylphenol  (EXP)
4-phenylbutyric acid  (ISO)
5'-S-methyl-5'-thioadenosine  (ISO)
5,6alpha-epoxy-5alpha-cholestan-3beta-ol  (EXP)
5-fluorouracil  (ISO)
5-methoxypsoralen  (ISO)
7,12-dimethyltetraphene  (ISO)
7-ketocholesterol  (EXP)
9-cis-retinoic acid  (ISO)
acadesine  (ISO)
acetaldehyde  (ISO)
acetic acid  (EXP)
acetylsalicylic acid  (ISO)
acrylamide  (EXP)
acrylonitrile  (ISO)
afimoxifene  (ISO)
aflatoxin B1  (ISO)
AICA ribonucleotide  (EXP,ISO)
Ajugasterone C  (ISO)
aldehydo-D-glucose  (EXP,ISO)
alpha-naphthoflavone  (ISO)
alpha-phellandrene  (ISO)
alternariol  (ISO)
amino acid  (ISO)
amiodarone  (ISO)
ammonium chloride  (EXP,ISO)
androst-4-ene-3,17-dione  (ISO)
antimycin A  (ISO)
antroquinonol  (ISO)
arachidonic acid  (ISO)
arecoline  (ISO)
Aroclor 1254  (EXP)
arsane  (ISO)
arsenic atom  (ISO)
arsenite(3-)  (EXP,ISO)
arsenous acid  (ISO)
artesunate  (ISO)
Asiaticoside  (EXP)
astragaloside IV  (EXP)
atorvastatin calcium  (EXP)
atrazine  (ISO)
aucubin  (ISO)
Auriculasin  (ISO)
azathioprine  (ISO)
bafilomycin A1  (ISO)
baicalein  (ISO)
benzo[a]pyrene  (ISO)
beta-thujaplicin  (ISO)
betalain  (ISO)
betulin  (ISO)
bis(2-ethylhexyl) phthalate  (EXP,ISO)
bisphenol A  (EXP,ISO)
butan-1-ol  (ISO)
butein  (ISO)
butyric acid  (ISO)
C.I. Natural Red 20  (ISO)
cadmium atom  (EXP,ISO)
cadmium dichloride  (EXP,ISO)
caffeine  (ISO)
calciol  (ISO)
calcium atom  (EXP)
calcium(0)  (EXP)
calix[6]arene  (ISO)
camptothecin  (ISO)
cannabidiol  (ISO)
capsaicin  (ISO)
carbon disulfide  (EXP,ISO)
carbon nanotube  (EXP,ISO)
carnosic acid  (ISO)
celastrol  (EXP)
cepharanthine  (ISO)
chicoric acid  (EXP)
chloroethene  (ISO)
chloroquine  (ISO)
chlorpyrifos  (ISO)
cholesterol  (ISO)
chromium(6+)  (EXP,ISO)
cisplatin  (EXP,ISO)
clobetasol  (ISO)
clofibrate  (EXP,ISO)
cobalt dichloride  (EXP,ISO)
colistin  (ISO)
copper atom  (ISO)
copper(0)  (ISO)
copper(II) chloride  (ISO)
corosolic acid  (ISO)
corticosterone  (ISO)
Corynoxine B  (ISO)
coumarin  (ISO)
creatine  (ISO)
cucurbitacin E  (EXP,ISO)
curcumin  (ISO)
Curcumol  (EXP)
cyclosporin A  (EXP)
D-glucose  (EXP,ISO)
dapagliflozin  (EXP)
daunorubicin  (ISO)
decabromodiphenyl ether  (ISO)
deguelin  (ISO)
deoxynivalenol  (ISO)
desferrioxamine B  (ISO)
dexamethasone  (ISO)
dextran sulfate  (EXP,ISO)
diallyl trisulfide  (ISO)
diarsenic trioxide  (ISO)
dibutyl phthalate  (EXP,ISO)
dicrotophos  (ISO)
Dictamnine  (ISO)
dieckol  (ISO)
dieldrin  (ISO)
diethylstilbestrol  (ISO)
Dihydrotanshinone I  (ISO)
dimercaprol  (ISO)
dioscin  (ISO)
diosgenin  (ISO)
dioxygen  (EXP,ISO)
dodecanoic acid  (ISO)
dopamine  (ISO)
dorsomorphin  (EXP,ISO)
doxorubicin  (EXP,ISO)
elemental selenium  (EXP)
epoxiconazole  (ISO)
erlotinib hydrochloride  (ISO)
ethanol  (EXP,ISO)
ethylene glycol bis(2-aminoethyl)tetraacetic acid  (EXP,ISO)
etoposide  (ISO)
everolimus  (EXP,ISO)
fenvalerate  (EXP,ISO)
fingolimod hydrochloride  (ISO)
flavanones  (ISO)
flavokawain B  (ISO)
fluoxetine  (EXP)
fluvastatin  (EXP)
fructose  (EXP)
fucoxanthin  (ISO)
fulvestrant  (ISO)
fumonisin B1  (ISO)
Fusaric acid  (ISO)
gabapentin  (ISO)
galangin  (ISO)
gefitinib  (ISO)
geraniol  (ISO)
gingerol  (ISO)
ginsenoside Rg1  (ISO)
glucose  (EXP,ISO)
glycerol 2-phosphate  (ISO)
glycyrrhizinic acid  (EXP)
glyphosate  (ISO)
gold atom  (ISO)
gold(0)  (ISO)
gossypetin  (ISO)
graphene oxide  (ISO)
hesperetin  (EXP)
hesperidin  (EXP)
hexachlorobenzene  (EXP)
hexadecanoic acid  (ISO)
HU-308  (EXP,ISO)
hydrogen peroxide  (EXP,ISO)
hydroxyurea  (ISO)
icariin  (EXP)
icariside II  (ISO)
idelalisib  (ISO)
isoprenaline  (EXP)
ivermectin  (ISO)
kahweol  (ISO)
L-ascorbic acid 2-phosphate  (ISO)
lapatinib  (ISO)
lead diacetate  (EXP,ISO)
lead nitrate  (EXP)
lead(0)  (ISO)
lead(2+)  (ISO)
letrozole  (ISO)
linagliptin  (EXP)
linsidomine  (EXP)
lipopolysaccharide  (ISO)
lithium atom  (ISO)
lithium chloride  (ISO)
lithium hydride  (ISO)
loperamide  (ISO)
Lupiwighteone  (ISO)
LY294002  (EXP,ISO)
magnesium atom  (EXP)
maneb  (ISO)
manganese atom  (EXP,ISO)
manganese(0)  (EXP,ISO)
manganese(II) chloride  (EXP,ISO)
melatonin  (ISO)
mesalamine  (EXP)
metformin  (EXP,ISO)
methamphetamine  (EXP,ISO)
methapyrilene  (EXP)
methyl caffeate  (ISO)
methylisothiazolinone  (ISO)
methyllycaconitine  (ISO)
methylmercury chloride  (EXP,ISO)
methylphenidate  (EXP)
microcystin-LR  (ISO)
mifepristone  (ISO)
mirtazapine  (EXP)
MK-2206  (ISO)
morin  (ISO)
Morroniside  (ISO)
N-acetyl-L-cysteine  (EXP,ISO)
N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal  (ISO)
N-ethyl-N-nitrosourea  (ISO)
N-methyl-4-phenylpyridinium  (EXP,ISO)
N-methyl-N-nitrosourea  (EXP)
N-methylnicotinate  (ISO)
N-nitrosodiethylamine  (EXP,ISO)
naringin  (EXP)
navitoclax  (ISO)
Neferine  (EXP)
nickel atom  (ISO)
nickel dichloride  (ISO)
niclosamide  (ISO)
nicotinamide  (ISO)
nicotine  (EXP,ISO)
nicotinic acid  (EXP)
nitric oxide  (ISO)
nobiletin  (EXP)
Nonylphenol  (EXP)
ochratoxin A  (ISO)
oleanolic acid  (ISO)
oligopeptide  (ISO)
omacetaxine mepesuccinate  (ISO)
oxaliplatin  (EXP,ISO)
ozone  (EXP)
p-cresol  (ISO)
paclitaxel  (ISO)
paeoniflorin  (EXP,ISO)
Paeonol  (EXP)
paracetamol  (ISO)
paraquat  (EXP,ISO)
patulin  (ISO)
PD 0325901  (ISO)
Pentoxifylline  (EXP)
perfluorooctanoic acid  (EXP,ISO)
perfluoroundecanoic acid  (EXP)
perhexiline  (ISO)
perifosine  (ISO)
phenylarsine oxide  (ISO)
phenylephrine  (EXP)
phloretin  (ISO)
phorbol 13-acetate 12-myristate  (ISO)
phosphatidic acid  (ISO)
piclamilast  (EXP)
pioglitazone  (ISO)
pirinixic acid  (ISO)
platycodin D  (ISO)
pravastatin  (ISO)
progesterone  (EXP,ISO)
promethazine  (ISO)
propofol  (ISO)
prostaglandin E2  (ISO)
prothioconazole  (ISO)
psoralen  (ISO)
puerarin  (EXP,ISO)
quercetin  (EXP,ISO)
radon atom  (ISO)
radon(0)  (ISO)
reactive oxygen species  (ISO)
Rebamipide  (ISO)
rebaudioside A  (ISO)
resveratrol  (EXP,ISO)
ribavirin  (ISO)
ridaforolimus  (ISO)
rotenone  (EXP,ISO)
rottlerin  (ISO)
ruthenium atom  (ISO)
Salidroside  (EXP)
sarpogrelate  (ISO)
SB 203580  (EXP)
SB 431542  (ISO)
selenium atom  (EXP)
serotonin  (ISO)
serpentine asbestos  (ISO)
sevoflurane  (ISO)
Shikonin  (ISO)
silicon dioxide  (EXP,ISO)
simvastatin  (ISO)
sirolimus  (EXP,ISO)
sodium arsenite  (ISO)
sodium fluoride  (EXP,ISO)
sonidegib  (EXP)
sorafenib  (ISO)
steviol  (ISO)
stevioside  (ISO)
stilbenoid  (ISO)
streptozocin  (EXP,ISO)
sulfadiazine  (ISO)
T-2 toxin  (EXP)
tadalafil  (ISO)
tamoxifen  (ISO)
taurine  (EXP)
tauroursodeoxycholic acid  (ISO)
temozolomide  (ISO)
Temsirolimus  (ISO)
tert-butyl hydroperoxide  (ISO)
testosterone  (EXP)
tetrahydropalmatine  (ISO)
tetramethylpyrazine  (ISO)
theobromine  (EXP)
thioacetamide  (ISO)
Thiorphan  (ISO)
thymoquinone  (ISO)
titanium dioxide  (ISO)
topotecan  (EXP,ISO)
torin 1  (ISO)
trabectedin  (ISO)
trans-piceid  (ISO)
tributylstannane  (EXP)
trichloroethene  (ISO)
triclosan  (EXP)
trifluoperazine  (EXP,ISO)
trimellitic anhydride  (ISO)
Triptolide  (ISO)
triptonide  (ISO)
tris(2-chloroethyl) phosphate  (ISO)
tungsten  (ISO)
tunicamycin  (ISO)
tyrphostin AG 1478  (EXP)
ursolic acid  (ISO)
usnic acid  (ISO)
valproic acid  (ISO)
vancomycin  (ISO)
verapamil  (EXP)
vorinostat  (ISO)
wortmannin  (ISO)
XL765  (ISO)
Y-27632  (ISO)
Yessotoxin  (ISO)
zearalenone  (EXP,ISO)
zidovudine  (EXP)
zinc oxide  (EXP,ISO)
zinc pyrithione  (ISO)
zingerone  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
'de novo' pyrimidine nucleobase biosynthetic process  (ISO)
behavioral response to pain  (ISO)
brain development  (IEP)
calcineurin-NFAT signaling cascade  (ISO)
cardiac cell development  (ISO)
cardiac muscle cell development  (ISO)
cardiac muscle contraction  (ISO)
cardiac muscle tissue development  (ISO)
cell projection organization  (IGI,ISO)
cellular component organization  (IEA)
cellular response to amino acid starvation  (ISO,ISS)
cellular response to amino acid stimulus  (ISO)
cellular response to hypoxia  (ISO,ISS)
cellular response to leucine  (ISO)
cellular response to leucine starvation  (ISO)
cellular response to nutrient levels  (ISO,ISS)
cellular response to starvation  (ISO,ISS)
energy reserve metabolic process  (ISO)
germ cell development  (ISO)
heart morphogenesis  (ISO)
heart valve morphogenesis  (ISO)
inflammatory response  (ISO)
long-term memory  (IMP)
lysosome organization  (ISO,ISS)
macroautophagy  (ISO)
maternal process involved in female pregnancy  (IDA)
mRNA stabilization  (IMP)
multicellular organism growth  (ISO)
negative regulation of autophagy  (IMP,ISO,ISS)
negative regulation of calcineurin-NFAT signaling cascade  (ISO)
negative regulation of cell size  (IMP,ISO)
negative regulation of cholangiocyte apoptotic process  (IMP)
negative regulation of iodide transmembrane transport  (IMP)
negative regulation of macroautophagy  (IBA,ISO)
negative regulation of muscle atrophy  (IMP)
negative regulation of protein phosphorylation  (IMP)
negative regulation of protein ubiquitination  (IMP)
neuronal action potential  (ISO)
nucleus localization  (ISO,ISS)
oligodendrocyte differentiation  (ISO)
peptidyl-serine phosphorylation  (ISO,ISS)
peptidyl-threonine phosphorylation  (ISO)
phosphorylation  (ISO)
positive regulation of actin filament polymerization  (ISO)
positive regulation of cell death  (IMP)
positive regulation of cell growth involved in cardiac muscle cell development  (IMP)
positive regulation of cellular senescence  (IMP)
positive regulation of cholangiocyte proliferation  (IMP)
positive regulation of dendritic spine development  (IMP)
positive regulation of eating behavior  (IMP)
positive regulation of endothelial cell proliferation  (IMP)
positive regulation of epithelial to mesenchymal transition  (ISO)
positive regulation of gene expression  (ISO)
positive regulation of glial cell proliferation  (IMP)
positive regulation of granulosa cell proliferation  (IMP)
positive regulation of keratinocyte migration  (ISO)
positive regulation of lamellipodium assembly  (ISO)
positive regulation of lipid biosynthetic process  (ISO,ISS)
positive regulation of myotube differentiation  (ISO)
positive regulation of neurogenesis  (IMP)
positive regulation of neuron death  (IMP)
positive regulation of neuron maturation  (IMP)
positive regulation of neuron projection development  (IMP)
positive regulation of nitric oxide biosynthetic process  (IMP)
positive regulation of oligodendrocyte differentiation  (IMP,ISO)
positive regulation of peptidyl-tyrosine phosphorylation  (ISO)
positive regulation of protein kinase B signaling  (IMP)
positive regulation of protein metabolic process  (IEA)
positive regulation of protein phosphorylation  (ISO)
positive regulation of sensory perception of pain  (IMP)
positive regulation of skeletal muscle hypertrophy  (IMP)
positive regulation of smooth muscle cell proliferation  (IMP)
positive regulation of stress fiber assembly  (ISO)
positive regulation of transcription by RNA polymerase III  (ISO)
positive regulation of transcription of nucleolar large rRNA by RNA polymerase I  (ISO)
positive regulation of translation  (IMP,ISO)
positive regulation of wound healing, spreading of epidermal cells  (ISO)
post-embryonic development  (ISO)
protein autophosphorylation  (IMP,ISO)
protein phosphorylation  (IBA,IDA,IEA,IMP,ISO)
regulation of actin cytoskeleton organization  (ISO)
regulation of autophagy  (ISO,ISS)
regulation of brown fat cell differentiation  (IMP)
regulation of carbohydrate metabolic process  (IDA,IMP)
regulation of carbohydrate utilization  (IDA,IMP)
regulation of cell growth  (ISO)
regulation of cell size  (ISO)
regulation of cellular component organization  (IEA)
regulation of circadian rhythm  (ISO,ISS)
regulation of fatty acid beta-oxidation  (IDA,IMP)
regulation of glycogen biosynthetic process  (IDA,IMP)
regulation of GTPase activity  (ISO)
regulation of locomotor rhythm  (ISO,ISS)
regulation of membrane permeability  (ISO)
regulation of myelination  (ISO)
regulation of nucleobase-containing compound metabolic process  (IEA)
regulation of osteoclast differentiation  (ISO,ISS)
regulation of protein kinase activity  (ISO)
regulation of protein kinase B signaling  (ISO)
regulation of protein phosphorylation  (ISO)
regulation of response to food  (IDA,IMP)
regulation of translation at synapse, modulating synaptic transmission  (EXP,IDA,IEP,IMP)
reproductive process  (IEA)
response to activity  (IEP)
response to amino acid  (ISO)
response to cocaine  (IMP)
response to heat  (ISO)
response to insulin  (ISO)
response to morphine  (IMP)
response to nutrient  (ISO)
response to nutrient levels  (ISO,ISS)
rhythmic process  (IEA)
ruffle organization  (ISO)
social behavior  (IMP)
spinal cord development  (IDA)
T-helper 1 cell lineage commitment  (ISO)
TOR signaling  (IBA,ISO,ISS)
TORC1 signaling  (ISO)
visual learning  (IMP)
voluntary musculoskeletal movement  (ISO)
wound healing  (IEP)

Cellular Component

References

References - curated
# Reference Title Reference Citation
1. Repetitive stretch suppresses denervation-induced atrophy of soleus muscle in rats. Agata N, etal., Muscle Nerve. 2009 Apr;39(4):456-62. doi: 10.1002/mus.21103.
2. New immunosuppresor strategies in the treatment of murine lupus nephritis. Alperovich G, etal., Lupus. 2007;16(1):18-24.
3. 2-Hydroxyestradiol slows progression of experimental polycystic kidney disease. Anderson S, etal., Am J Physiol Renal Physiol. 2012 Mar 1;302(5):F636-45. doi: 10.1152/ajprenal.00265.2011. Epub 2011 Dec 7.
4. Mammalian target of rapamycin signaling in the spinal cord is required for neuronal plasticity and behavioral hypersensitivity associated with neuropathy in the rat. Asante CO, etal., J Pain. 2010 Dec;11(12):1356-67. doi: 10.1016/j.jpain.2010.03.013. Epub 2010 May 8.
5. Testosterone signals through mTOR and androgen receptor to induce muscle hypertrophy. Basualto-Alarcon C, etal., Med Sci Sports Exerc. 2013 Sep;45(9):1712-20. doi: 10.1249/MSS.0b013e31828cf5f3.
6. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. Bolster DR, etal., J Biol Chem 2002 Jul 5;277(27):23977-80.
7. The mTOR/p70S6K signal transduction pathway plays a role in cardiac hypertrophy and influences expression of myosin heavy chain genes in vivo. Boluyt MO, etal., Cardiovasc Drugs Ther. 2004 Jul;18(4):257-67.
8. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Brunn GJ, etal., Science. 1997 Jul 4;277(5322):99-101.
9. Autophagy activation by rapamycin reduces severity of experimental osteoarthritis. Carames B, etal., Ann Rheum Dis. 2012 Apr;71(4):575-81. doi: 10.1136/annrheumdis-2011-200557. Epub 2011 Nov 14.
10. CaMKII is involved in cadmium activation of MAPK and mTOR pathways leading to neuronal cell death. Chen S, etal., J Neurochem. 2011 Dec;119(5):1108-18. doi: 10.1111/j.1471-4159.2011.07493.x. Epub 2011 Oct 20.
11. mTORC1/2 targeted by n-3 polyunsaturated fatty acids in the prevention of mammary tumorigenesis and tumor progression. Chen Z, etal., Oncogene. 2014 Sep 11;33(37):4548-57. doi: 10.1038/onc.2013.402. Epub 2013 Oct 7.
12. Hypothalamic mTOR signaling regulates food intake. Cota D, etal., Science. 2006 May 12;312(5775):927-30.
13. [Effect of granulocyte-macrophage colony-stimulating factor on the mammalian target of sirolimus signaling pathway in the wound of rat]. Cui WH, etal., Zhonghua Shao Shang Za Zhi. 2012 Feb;28(1):36-41.
14. Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: incidence, radiographic findings and correlation with clinical outcome. Dabydeen DA, etal., Eur J Cancer. 2012 Jul;48(10):1519-24. doi: 10.1016/j.ejca.2012.03.012. Epub 2012 Apr 5.
15. MTOR downregulates iodide uptake in thyrocytes. de Souza EC, etal., J Endocrinol. 2010 Jul;206(1):113-20. doi: 10.1677/JOE-09-0436. Epub 2010 Apr 14.
16. mTOR inhibition alleviates L-DOPA-induced dyskinesia in parkinsonian rats. Decressac M and Bjorklund A, J Parkinsons Dis. 2013;3(1):13-7. doi: 10.3233/JPD-120155.
17. Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation. Dello Russo C, etal., Biochem Pharmacol. 2009 Nov 1;78(9):1242-51. doi: 10.1016/j.bcp.2009.06.097. Epub 2009 Jul 1.
18. Neurogenin 3-directed cre deletion of Tsc1 gene causes pancreatic acinar carcinoma. Ding L, etal., Neoplasia. 2014 Nov 20;16(11):909-17. doi: 10.1016/j.neo.2014.08.010. eCollection 2014 Nov.
19. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Fingar DC, etal., Genes Dev 2002 Jun 15;16(12):1472-87.
20. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
21. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Gingras AC, etal., Genes Dev. 1999 Jun 1;13(11):1422-37.
22. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
23. Phospho-mTOR: a novel target in regulation of renal lipid metabolism abnormality of diabetes. Hao J, etal., Exp Cell Res. 2013 Aug 15;319(14):2296-306. doi: 10.1016/j.yexcr.2013.06.013. Epub 2013 Jul 1.
24. Rapamycin treatment augments both protein ubiquitination and Akt activation in pressure-overloaded rat myocardium. Harston RK, etal., Am J Physiol Heart Circ Physiol. 2011 May;300(5):H1696-706. doi: 10.1152/ajpheart.00545.2010. Epub 2011 Feb 25.
25. Advanced glycation endproducts trigger autophagy in cadiomyocyte via RAGE/PI3K/AKT/mTOR pathway. Hou X, etal., Cardiovasc Diabetol. 2014 Apr 14;13:78. doi: 10.1186/1475-2840-13-78.
26. Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension. Houssaini A, etal., Am J Respir Cell Mol Biol. 2013 May;48(5):568-77. doi: 10.1165/rcmb.2012-0429OC.
27. ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats. Hu LY, etal., Neuroscience. 2010 Sep 1;169(3):1046-62. doi: 10.1016/j.neuroscience.2010.05.046. Epub 2010 Jun 1.
28. Decrease in transient receptor potential melastatin 6 mRNA stability caused by rapamycin in renal tubular epithelial cells. Ikari A, etal., Biochim Biophys Acta. 2011 Jun;1808(6):1502-8. doi: 10.1016/j.bbamem.2010.11.006. Epub 2010 Nov 10.
29. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. Inoki K, etal., J Clin Invest. 2011 Jun;121(6):2181-96. doi: 10.1172/JCI44771. Epub 2011 May 23.
30. Mammalian target of rapamycin is activated in association with myometrial proliferation during pregnancy. Jaffer S, etal., Endocrinology. 2009 Oct;150(10):4672-80. doi: 10.1210/en.2009-0419. Epub 2009 Jul 9.
31. Activation of mammalian target of rapamycin contributes to pain nociception induced in rats by BmK I, a sodium channel-specific modulator. Jiang F, etal., Neurosci Bull. 2014 Feb;30(1):21-32. doi: 10.1007/s12264-013-1377-0. Epub 2013 Oct 16.
32. MicroRNA-Related Polymorphisms in PI3K/Akt/mTOR Pathway Genes Are Predictive of Limited-Disease Small Cell Lung Cancer Treatment Outcomes. Jiang W, etal., Biomed Res Int. 2017;2017:6501385. doi: 10.1155/2017/6501385. Epub 2017 Feb 9.
33. Atorvastatin enhances neurite outgrowth in cortical neurons in vitro via up-regulating the Akt/mTOR and Akt/GSK-3beta signaling pathways. Jin Y, etal., Acta Pharmacol Sin. 2012 Jul;33(7):861-72. doi: 10.1038/aps.2012.59. Epub 2012 Jun 18.
34. Influence of Rictor and Raptor Expression of mTOR Signaling on Long-Term Outcomes of Patients with Hepatocellular Carcinoma. Kaibori M, etal., Dig Dis Sci. 2015 Apr;60(4):919-28. doi: 10.1007/s10620-014-3417-7. Epub 2014 Nov 5.
35. mTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1-JNK pathway. Kato H, etal., Cell Death Differ. 2012 Feb;19(2):310-20. doi: 10.1038/cdd.2011.98. Epub 2011 Jul 22.
36. Sepsis-induced alterations in protein-protein interactions within mTOR complex 1 and the modulating effect of leucine on muscle protein synthesis. Kazi AA, etal., Shock. 2011 Feb;35(2):117-25. doi: 10.1097/SHK.0b013e3181ecb57c.
37. The role of autophagy in unilateral ureteral obstruction rat model. Kim WY, etal., Nephrology (Carlton). 2012 Feb;17(2):148-59. doi: 10.1111/j.1440-1797.2011.01541.x.
38. The mTOR-inhibitor rapamycin mediates proteinuria in nephrotoxic serum nephritis by activating the innate immune response. Kirsch AH, etal., Am J Physiol Renal Physiol. 2012 Aug 15;303(4):F569-75. doi: 10.1152/ajprenal.00180.2012. Epub 2012 Jun 13.
39. Role of amino acid transporter LAT2 in the activation of mTORC1 pathway and the pathogenesis of crescentic glomerulonephritis. Kurayama R, etal., Lab Invest. 2011 Jul;91(7):992-1006. doi: 10.1038/labinvest.2011.43. Epub 2011 Mar 14.
40. Delayed mTOR inhibition with low dose of everolimus reduces TGFbeta expression, attenuates proteinuria and renal damage in the renal mass reduction model. Kurdian M, etal., PLoS One. 2012;7(3):e32516. doi: 10.1371/journal.pone.0032516. Epub 2012 Mar 12.
41. Hippocampal long term memory: effect of the cholinergic system on local protein synthesis. Lana D, etal., Neurobiol Learn Mem. 2013 Nov;106:246-57. doi: 10.1016/j.nlm.2013.09.013. Epub 2013 Sep 27.
42. mTOR signaling in growth control and disease. Laplante M and Sabatini DM, Cell. 2012 Apr 13;149(2):274-93. doi: 10.1016/j.cell.2012.03.017.
43. Insulin promotes dendritic spine and synapse formation by the PI3K/Akt/mTOR and Rac1 signaling pathways. Lee CC, etal., Neuropharmacology. 2011 Sep;61(4):867-79. doi: 10.1016/j.neuropharm.2011.06.003. Epub 2011 Jun 12.
44. BAFF/BAFF-R involved in antibodies production of rats with collagen-induced arthritis via PI3K-Akt-mTOR signaling and the regulation of paeoniflorin. Li PP, etal., J Ethnopharmacol. 2012 May 7;141(1):290-300. doi: 10.1016/j.jep.2012.02.034. Epub 2012 Feb 27.
45. Hypoxia-induced endothelial proliferation requires both mTORC1 and mTORC2. Li W, etal., Circ Res. 2007 Jan 5;100(1):79-87. Epub 2006 Nov 16.
46. Association between AKT/mTOR signalling pathway and malignancy grade of human gliomas. Li XY, etal., J Neurooncol. 2011 Jul;103(3):453-8. doi: 10.1007/s11060-010-0424-1. Epub 2010 Sep 29.
47. TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity. Liang MC, etal., Oncogene. 2010 Mar 18;29(11):1588-97. doi: 10.1038/onc.2009.452. Epub 2009 Dec 7.
48. Antiproliferation of cardamonin is involved in mTOR on aortic smooth muscle cells in high fructose-induced insulin resistance rats. Liao Q, etal., Eur J Pharmacol. 2010 Sep 1;641(2-3):179-86. doi: 10.1016/j.ejphar.2010.05.024. Epub 2010 Jun 4.
49. Inhibition of mammalian target of rapamycin improves neurobehavioral deficit and modulates immune response after intracerebral hemorrhage in rat. Lu Q, etal., J Neuroinflammation. 2014 Mar 6;11:44. doi: 10.1186/1742-2094-11-44.
50. Activation of the Renal PI3K/Akt/mTOR Signaling Pathway in a DOCA-Salt Model of Hypertension. Ma SK, etal., Chonnam Med J. 2012 Dec;48(3):150-4. doi: 10.4068/cmj.2012.48.3.150. Epub 2012 Dec 21.
51. Molecular mechanisms of mTOR-mediated translational control. Ma XM and Blenis J, Nat Rev Mol Cell Biol. 2009 May;10(5):307-18. Epub 2009 Apr 2.
52. mTOR and tau phosphorylated proteins in the hippocampal tissue of rats with type 2 diabetes and Alzheimer's disease. Ma YQ, etal., Mol Med Rep. 2013 Feb;7(2):623-7. doi: 10.3892/mmr.2012.1186. Epub 2012 Nov 15.
53. Spatiotemporal characterization of mTOR kinase activity following kainic acid induced status epilepticus and analysis of rat brain response to chronic rapamycin treatment. Macias M, etal., PLoS One. 2013 May 28;8(5):e64455. doi: 10.1371/journal.pone.0064455. Print 2013.
54. Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease. Malagelada C, etal., J Neurosci. 2010 Jan 20;30(3):1166-75. doi: 10.1523/JNEUROSCI.3944-09.2010.
55. Drug-related pneumonitis in patients with advanced renal cell carcinoma treated with temsirolimus. Maroto JP, etal., J Clin Oncol. 2011 May 1;29(13):1750-6. doi: 10.1200/JCO.2010.29.2235. Epub 2011 Mar 28.
56. Role of insulin, adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity, and cancer. Marshall S Sci STKE. 2006 Aug 1;2006(346):re7.
57. Effects of leucine supplementation and resistance training on myopathy of diabetic rats. Martins CEC, etal., Physiol Rep. 2017 May;5(10). pii: 5/10/e13273. doi: 10.14814/phy2.13273.
58. 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. Meffre J, etal., EMBO Mol Med. 2012 Oct;4(10):1043-56. doi: 10.1002/emmm.201201410.
59. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
60. Thyroid hormone improves the mechanical performance of the post-infarcted diabetic myocardium: a response associated with up-regulation of Akt/mTOR and AMPK activation. Mourouzis I, etal., Metabolism. 2013 Oct;62(10):1387-93. doi: 10.1016/j.metabol.2013.05.008. Epub 2013 Jun 15.
61. Involvement of autophagy in the pharmacological effects of the mTOR inhibitor everolimus in acute kidney injury. Nakagawa S, etal., Eur J Pharmacol. 2012 Dec 5;696(1-3):143-54. doi: 10.1016/j.ejphar.2012.09.010. Epub 2012 Sep 26.
62. Electronic Transfer of LocusLink and RefSeq Data NCBI rat LocusLink and RefSeq merged data July 26, 2002
63. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
64. Inhibition of chondrosarcoma growth by mTOR inhibitor in an in vivo syngeneic rat model. Perez J, etal., PLoS One. 2012;7(6):e32458. doi: 10.1371/journal.pone.0032458. Epub 2012 Jun 27.
65. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Peterson TR, etal., Cell. 2009 May 29;137(5):873-86. doi: 10.1016/j.cell.2009.03.046. Epub 2009 May 14.
66. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
67. PID Annotation Import Pipeline Pipeline to import Pathway Interaction Database annotations from NCI into RGD
68. mTOR inhibitor RAD001 promotes metastasis in a rat model of pancreatic neuroendocrine cancer. Pool SE, etal., Cancer Res. 2013 Jan 1;73(1):12-8. doi: 10.1158/0008-5472.CAN-11-2089. Epub 2012 Nov 13.
69. Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways. Pratheeshkumar P, etal., PLoS One. 2012;7(10):e47516. doi: 10.1371/journal.pone.0047516. Epub 2012 Oct 18.
70. Inactivation of p53 and Pten promotes invasive bladder cancer. Puzio-Kuter AM, etal., Genes Dev. 2009 Mar 15;23(6):675-80. doi: 10.1101/gad.1772909. Epub 2009 Mar 4.
71. Activation of mammalian target of rapamycin signaling in spatial learning. Qi S, etal., Neurosci Res. 2010 Oct;68(2):88-93. doi: 10.1016/j.neures.2010.06.008. Epub 2010 Jun 25.
72. mTOR Plays a Critical Role in p53-induced Oxidative Kidney Cell Injury in HIVAN. Rai P, etal., Am J Physiol Renal Physiol. 2013 May 15.
73. Activation of the PI3K/mTOR pathway is involved in cystic proliferation of cholangiocytes of the PCK rat. Ren XS, etal., PLoS One. 2014 Jan 30;9(1):e87660. doi: 10.1371/journal.pone.0087660. eCollection 2014.
74. GOA pipeline RGD automated data pipeline
75. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
76. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
77. Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. Risson V, etal., J Cell Biol. 2009 Dec 14;187(6):859-74. doi: 10.1083/jcb.200903131.
78. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Sabatini DM, etal., Cell 1994 Jul 15;78(1):35-43.
79. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. Sabers CJ, etal., J Biol Chem 1995 Jan 13;270(2):815-22.
80. Redox-sensitive prosurvival and proapoptotic protein expression in the myocardial remodeling post-infarction in rats. Schenkel PC, etal., Mol Cell Biochem. 2010 Aug;341(1-2):1-8. doi: 10.1007/s11010-010-0431-8. Epub 2010 Mar 30.
81. Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas. Schultz L, etal., Am J Surg Pathol. 2011 Oct;35(10):1549-56. doi: 10.1097/PAS.0b013e31822895e5.
82. PTEN deletion prevents ischemic brain injury by activating the mTOR signaling pathway. Shi GD, etal., Biochem Biophys Res Commun. 2011 Jan 28;404(4):941-5. doi: 10.1016/j.bbrc.2010.12.085. Epub 2010 Dec 23.
83. Oncopreventive effects of theanine and theobromine on dimethylhydrazine-induced colon cancer model. Shojaei-Zarghani S, etal., Biomed Pharmacother. 2021 Feb;134:111140. doi: 10.1016/j.biopha.2020.111140. Epub 2020 Dec 24.
84. Rapamycin-mediated inhibition of mammalian target of rapamycin in skeletal muscle cells reduces glucose utilization and increases fatty acid oxidation. Sipula IJ, etal., Metabolism. 2006 Dec;55(12):1637-44.
85. Sirolimus produced S-shaped effect on adult polycystic kidneys after 2-year treatment. Soliman A, etal., Transplant Proc. 2012 Dec;44(10):2936-9. doi: 10.1016/j.transproceed.2012.06.073.
86. mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy. Song X, etal., Am J Physiol Cell Physiol. 2010 Dec;299(6):C1256-66. doi: 10.1152/ajpcell.00338.2010. Epub 2010 Sep 22.
87. Nephron-sparing resection of angiomyolipoma after sirolimus pretreatment in patients with tuberous sclerosis. Staehler M, etal., Int Urol Nephrol. 2012 Dec;44(6):1657-61. doi: 10.1007/s11255-012-0292-z. Epub 2012 Sep 28.
88. Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK. Storozhuk Y, etal., Br J Cancer. 2013 May 28;108(10):2021-32. doi: 10.1038/bjc.2013.187. Epub 2013 Apr 30.
89. Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. Takei N, etal., J Neurosci. 2004 Nov 3;24(44):9760-9.
90. A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Tang SJ, etal., Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):467-72. doi: 10.1073/pnas.012605299. Epub 2001 Dec 26.
91. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Tavazoie SF, etal., Nat Neurosci. 2005 Dec;8(12):1727-34. Epub 2005 Nov 6.
92. Tentative Sequence Identification Numbers Tentative Sequence Data IDs. TIGR Gene Index, Rat Data
93. Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation. Tyler WA, etal., J Neurosci. 2009 May 13;29(19):6367-78. doi: 10.1523/JNEUROSCI.0234-09.2009.
94. Acute alcohol intoxication enhances myocardial eIF4G phosphorylation despite reducing mTOR signaling. Vary TC, etal., Am J Physiol Heart Circ Physiol. 2005 Jan;288(1):H121-8. Epub 2004 Sep 23.
95. Adenosine 5'-monophosphate-activated protein kinase-mammalian target of rapamycin cross talk regulates brown adipocyte differentiation. Vila-Bedmar R, etal., Endocrinology. 2010 Mar;151(3):980-92. doi: 10.1210/en.2009-0810. Epub 2010 Feb 4.
96. Resveratrol pre-treatment reduces early inflammatory responses induced by status epilepticus via mTOR signaling. Wang SJ, etal., Brain Res. 2012 Dec 1. pii: S0006-8993(12)01821-5. doi: 10.1016/j.brainres.2012.11.027.
97. Rapamycin ameliorates inflammation and fibrosis in the early phase of cirrhotic portal hypertension in rats through inhibition of mTORC1 but not mTORC2. Wang W, etal., PLoS One. 2014 Jan 3;9(1):e83908. doi: 10.1371/journal.pone.0083908. eCollection 2014.
98. Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis. Wen ZH, etal., Oncogene. 2013 Jan 10;32(2):160-70. doi: 10.1038/onc.2012.47. Epub 2012 Feb 20.
99. Inhibition of the mammalian target of rapamycin pathway by rapamycin blocks cocaine-induced locomotor sensitization. Wu J, etal., Neuroscience. 2011 Jan 13;172:104-9. doi: 10.1016/j.neuroscience.2010.10.041. Epub 2010 Oct 25.
100. Characterization of ubiquilin 1, an mTOR-interacting protein. Wu S, etal., Biochim Biophys Acta 2002 Jan 30;1542(1-3):41-56.
101. Essential amino acid enriched high-protein enteral nutrition modulates insulin-like growth factor-1 system function in a rat model of trauma-hemorrhagic shock. Xia X, etal., PLoS One. 2013 Oct 28;8(10):e77823. doi: 10.1371/journal.pone.0077823. eCollection 2013.
102. Ischemic post-conditioning facilitates brain recovery after stroke by promoting Akt/mTOR activity in nude rats. Xie R, etal., J Neurochem. 2013 Dec;127(5):723-32. doi: 10.1111/jnc.12342. Epub 2013 Jul 8.
103. mTOR partly mediates insulin resistance by phosphorylation of insulin receptor substrate-1 on serine(307) residues after burn. Xin-Long C, etal., Burns. 2011 Feb;37(1):86-93. doi: 10.1016/j.burns.2010.04.005. Epub 2010 Jul 1.
104. PRAS40 plays a pivotal role in protecting against stroke by linking the Akt and mTOR pathways. Xiong X, etal., Neurobiol Dis. 2014 Jun;66:43-52. doi: 10.1016/j.nbd.2014.02.006. Epub 2014 Feb 27.
105. Proteomic Analysis of Hydroxysafflor Yellow A Against Cerebral Ischemia/Reperfusion Injury in Rats. Xu H, etal., Rejuvenation Res. 2019 Dec;22(6):503-512. doi: 10.1089/rej.2018.2145. Epub 2019 Mar 19.
106. Opioid receptor-triggered spinal mTORC1 activation contributes to morphine tolerance and hyperalgesia. Xu JT, etal., J Clin Invest. 2014 Feb;124(2):592-603. doi: 10.1172/JCI70236. Epub 2014 Jan 2.
107. The mechanisms of EGFR in the regulation of axon regeneration. Xu MF, etal., Cell Biochem Funct. 2014 Jan;32(1):101-5. doi: 10.1002/cbf.2977. Epub 2013 May 17.
108. Anti-angiogenic effects of mammalian target of rapamycin inhibitors in a mouse model of oxygen-induced retinopathy. Yagasaki R, etal., Biol Pharm Bull. 2014;37(11):1838-42.
109. Leucine stimulates insulin secretion via down-regulation of surface expression of adrenergic alpha2A receptor through the mTOR (mammalian target of rapamycin) pathway: implication in new-onset diabetes in renal transplantation. Yang J, etal., J Biol Chem. 2012 Jul 13;287(29):24795-806. doi: 10.1074/jbc.M112.344259. Epub 2012 May 29.
110. Integration analysis of quantitative proteomics and transcriptomics data identifies potential targets of frizzled-8 protein-related antiproliferative factor in vivo. Yang W, etal., BJU Int. 2012 Dec;110(11 Pt C):E1138-46. doi: 10.1111/j.1464-410X.2012.11299.x. Epub 2012 Jun 28.
111. Cross talk between estradiol and mTOR kinase in the regulation of ovarian granulosa proliferation. Yu J, etal., Reprod Sci. 2012 Feb;19(2):143-51. doi: 10.1177/1933719111424447.
112. mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy. Zeidan A, etal., Mol Cell Biochem. 2011 Jun;352(1-2):99-108. doi: 10.1007/s11010-011-0744-2. Epub 2011 Feb 13.
113. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. Zeng LH, etal., J Neurosci. 2009 May 27;29(21):6964-72. doi: 10.1523/JNEUROSCI.0066-09.2009.
114. Abeta40 modulates GABA(A) receptor alpha6 subunit expression and rat cerebellar granule neuron maturation through the ERK/mTOR pathway. Zhan XQ, etal., J Neurochem. 2014 Feb;128(3):350-62. doi: 10.1111/jnc.12471. Epub 2013 Oct 24.
115. [Tsc1 promoter methylation rate, mTOR expression in food-induced obese rat hypothalamus]. Zhang L, etal., Sichuan Da Xue Xue Bao Yi Xue Ban. 2015 Jan;46(1):47-50.
116. Abrogation of chronic rejection in rat model system involves modulation of the mTORC1 and mTORC2 pathways. Zhang L, etal., Transplantation. 2013 Nov 15;96(9):782-90. doi: 10.1097/TP.0b013e3182a2034f.
117. Enhancement of chondrocyte autophagy is an early response in the degenerative cartilage of the temporomandibular joint to biomechanical dental stimulation. Zhang M, etal., Apoptosis. 2013 Apr;18(4):423-34. doi: 10.1007/s10495-013-0811-0.
118. Modulation of food intake by mTOR signalling in the dorsal motor nucleus of the vagus in male rats: focus on ghrelin and nesfatin-1. Zhang W, etal., Exp Physiol. 2013 Dec;98(12):1696-704. doi: 10.1113/expphysiol.2013.074930. Epub 2013 Aug 16.
119. Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis. Zhang Y, etal., Ann Rheum Dis. 2014 Mar 20. doi: 10.1136/annrheumdis-2013-204599.
120. Paeoniflorin alleviates liver fibrosis by inhibiting HIF-1alpha through mTOR-dependent pathway. Zhao Y, etal., Fitoterapia. 2014 Dec;99:318-27. doi: 10.1016/j.fitote.2014.10.009. Epub 2014 Oct 16.
121. Effect of electroacupuncture on the expression of mTOR and eIF4E in hippocampus of rats with vascular dementia. Zhu Y, etal., Neurol Sci. 2013 Jul;34(7):1093-7. doi: 10.1007/s10072-012-1209-4. Epub 2012 Oct 9.
122. Expression and mechanism of mammalian target of rapamycin in age-related renal cell senescence and organ aging. Zhuo L, etal., Mech Ageing Dev. 2009 Oct;130(10):700-8. doi: 10.1016/j.mad.2009.08.005. Epub 2009 Aug 19.
Additional References at PubMed
PMID:10325225   PMID:10471835   PMID:11438723   PMID:11707573   PMID:12140361   PMID:12150926   PMID:12522136   PMID:12718876   PMID:12766174   PMID:12881204   PMID:12935885   PMID:12937293  
PMID:14610086   PMID:14679009   PMID:14769825   PMID:15001544   PMID:15010853   PMID:15185396   PMID:15292249   PMID:15304378   PMID:15389631   PMID:15467718   PMID:15494402   PMID:15591312  
PMID:15604215   PMID:15613684   PMID:15692808   PMID:15886222   PMID:16027121   PMID:16079186   PMID:16344552   PMID:16408196   PMID:16455781   PMID:16507764   PMID:16597691   PMID:16710051  
PMID:16714284   PMID:16717100   PMID:16885218   PMID:16885413   PMID:16915281   PMID:17005863   PMID:17023663   PMID:17028174   PMID:17074751   PMID:17203200   PMID:17284572   PMID:17374702  
PMID:17429052   PMID:17510244   PMID:17556672   PMID:17698034   PMID:17885021   PMID:17897319   PMID:17950100   PMID:18097751   PMID:18160036   PMID:18221855   PMID:18247380   PMID:18262357  
PMID:18265001   PMID:18347059   PMID:18347658   PMID:18365011   PMID:18377870   PMID:18381428   PMID:18410586   PMID:18466337   PMID:18497260   PMID:18556237   PMID:18593953   PMID:18620060  
PMID:18641049   PMID:18651560   PMID:18660503   PMID:18663086   PMID:18670866   PMID:18695678   PMID:18722381   PMID:18762023   PMID:18842593   PMID:18925875   PMID:19297425   PMID:19340459  
PMID:19348060   PMID:19401455   PMID:19403715   PMID:19440205   PMID:19453943   PMID:19509187   PMID:19515910   PMID:19539716   PMID:19547753   PMID:19622787   PMID:19648118   PMID:19704009  
PMID:19734277   PMID:19818818   PMID:19846571   PMID:19883644   PMID:19884565   PMID:19940197   PMID:19946888   PMID:19961888   PMID:20019183   PMID:20152809   PMID:20187447   PMID:20206401  
PMID:20233713   PMID:20352108   PMID:20368999   PMID:20381137   PMID:20399760   PMID:20466002   PMID:20473743   PMID:20513425   PMID:20517583   PMID:20526321   PMID:20537536   PMID:20538043  
PMID:20543138   PMID:20890458   PMID:20976781   PMID:21041654   PMID:21045808   PMID:21208419   PMID:21258367   PMID:21285325   PMID:21289215   PMID:21368105   PMID:21371020   PMID:21404070  
PMID:21439355   PMID:21472380   PMID:21478152   PMID:21525000   PMID:21602475   PMID:21613414   PMID:21720156   PMID:21750711   PMID:21858874   PMID:21876538   PMID:21925170   PMID:21949366  
PMID:22021677   PMID:22104347   PMID:22170591   PMID:22178140   PMID:22205374   PMID:22242835   PMID:22275758   PMID:22294347   PMID:22341316   PMID:22343943   PMID:22378614   PMID:22424946  
PMID:22467681   PMID:22513717   PMID:22567115   PMID:22576015   PMID:22577289   PMID:22684415   PMID:22692423   PMID:22768106   PMID:22802527   PMID:22848442   PMID:22875481   PMID:22889863  
PMID:22899279   PMID:22999929   PMID:23056530   PMID:23142719   PMID:23167446   PMID:23193052   PMID:23197407   PMID:23197706   PMID:23239524   PMID:23265586   PMID:23274896   PMID:23342106  
PMID:23372143   PMID:23395931   PMID:23429704   PMID:23566837   PMID:23583278   PMID:23607966   PMID:23618858   PMID:23707523   PMID:23726960   PMID:23728790   PMID:23788393   PMID:23836929  
PMID:23852509   PMID:23920219   PMID:23994018   PMID:24006279   PMID:24011591   PMID:24036451   PMID:24040371   PMID:24067463   PMID:24068000   PMID:24101522   PMID:24127984   PMID:24131573  
PMID:24194502   PMID:24270265   PMID:24374752   PMID:24462113   PMID:24576152   PMID:24667246   PMID:24670654   PMID:24797554   PMID:24801387   PMID:24889507   PMID:24889758   PMID:24976516  
PMID:25001019   PMID:25017576   PMID:25029414   PMID:25040634   PMID:25047835   PMID:25056347   PMID:25057926   PMID:25139234   PMID:25146548   PMID:25218136   PMID:25288788   PMID:25294810  
PMID:25304210   PMID:25327288   PMID:25358492   PMID:25411504   PMID:25428129   PMID:25471136   PMID:25479925   PMID:25674207   PMID:25706655   PMID:25759412   PMID:25816157   PMID:25871970  
PMID:25888508   PMID:25918725   PMID:25924882   PMID:25936802   PMID:25944900   PMID:26018084   PMID:26120832   PMID:26160071   PMID:26164831   PMID:26181632   PMID:26271595   PMID:26362885  
PMID:26400964   PMID:26409044   PMID:26410627   PMID:26449613   PMID:26558695   PMID:26572647   PMID:26636543   PMID:26648565   PMID:26695882   PMID:26706460   PMID:26770837   PMID:26823769  
PMID:26847932   PMID:27035760   PMID:27049295   PMID:27105917   PMID:27163752   PMID:27217700   PMID:27223630   PMID:27235551   PMID:27367537   PMID:27423593   PMID:27458160   PMID:27502839  
PMID:27631411   PMID:27762461   PMID:27791458   PMID:27891586   PMID:27919618   PMID:27997905   PMID:28025572   PMID:28041982   PMID:28084108   PMID:28130174   PMID:28147330   PMID:28161641  
PMID:28198521   PMID:28213972   PMID:28223137   PMID:28320092   PMID:28320103   PMID:28340591   PMID:28686615   PMID:28689409   PMID:28759157   PMID:28855439   PMID:28928406   PMID:28939765  
PMID:29084578   PMID:29127238   PMID:29137981   PMID:29237506   PMID:29277549   PMID:29278652   PMID:29287199   PMID:29311141   PMID:29315934   PMID:29353374   PMID:29466698   PMID:29506051  
PMID:29509258   PMID:29563162   PMID:29674181   PMID:29695414   PMID:29719042   PMID:29737948   PMID:29750193   PMID:29750810   PMID:29762821   PMID:29786755   PMID:29803175   PMID:29916537  
PMID:29956767   PMID:29975938   PMID:30030400   PMID:30041644   PMID:30050390   PMID:30066841   PMID:30089868   PMID:30317878   PMID:30391592   PMID:30444896   PMID:30541899   PMID:30704899  
PMID:30755615   PMID:30789219   PMID:30887674   PMID:30905926   PMID:30940563   PMID:30956113   PMID:31274018   PMID:31309116   PMID:31368880   PMID:31462148   PMID:31517703   PMID:31534118  
PMID:31593688   PMID:31698999   PMID:31759056   PMID:31899964   PMID:31994822   PMID:32003536   PMID:32061737   PMID:32124939   PMID:32236586   PMID:32383265   PMID:32572931   PMID:32651677  
PMID:32712090   PMID:32713334   PMID:32715402   PMID:32867795   PMID:32940340   PMID:33086033   PMID:33212156   PMID:33245682   PMID:33378666   PMID:33537831   PMID:33990769   PMID:33992580  
PMID:34071043   PMID:34138410   PMID:34265467   PMID:34278477   PMID:34338399   PMID:34338758   PMID:34374900   PMID:34655015   PMID:34736532   PMID:34874016   PMID:34926690   PMID:35030973  
PMID:35276811   PMID:35727683   PMID:35904584   PMID:35926274   PMID:36527650  


Genomics

Comparative Map Data
Mtor
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
mRatBN7.25158,884,856 - 158,994,311 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl5158,884,804 - 158,994,311 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx5161,601,607 - 161,711,017 (+)NCBIRnor_SHR
UTH_Rnor_SHRSP_BbbUtx_1.05163,423,732 - 163,533,437 (+)NCBIRnor_SHRSP
UTH_Rnor_WKY_Bbb_1.05163,380,079 - 163,489,786 (+)NCBIRnor_WKY
Rnor_6.05165,263,813 - 165,373,967 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl5165,263,800 - 165,373,967 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.05168,920,414 - 169,030,568 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.45165,531,402 - 165,640,899 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.15165,541,594 - 165,651,087 (+)NCBI
Celera5157,161,454 - 157,270,899 (+)NCBICelera
Cytogenetic Map5q36NCBI
MTOR
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38111,106,535 - 11,262,551 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p13 Ensembl111,106,535 - 11,262,556 (-)EnsemblGRCh38hg38GRCh38
GRCh37111,166,592 - 11,322,608 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 36111,089,179 - 11,245,153 (-)NCBINCBI36Build 36hg18NCBI36
Build 34111,100,857 - 11,256,830NCBI
Celera110,278,903 - 10,434,848 (-)NCBICelera
Cytogenetic Map1p36.22NCBI
HuRef110,317,883 - 10,473,910 (-)NCBIHuRef
CHM1_1111,154,542 - 11,310,885 (-)NCBICHM1_1
T2T-CHM13v2.0110,648,106 - 10,804,142 (-)NCBIT2T-CHM13v2.0
Mtor
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm394148,533,039 - 148,642,142 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl4148,533,068 - 148,642,140 (+)EnsemblGRCm39 Ensembl
GRCm384148,448,582 - 148,557,685 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl4148,448,611 - 148,557,683 (+)EnsemblGRCm38mm10GRCm38
MGSCv374147,822,691 - 147,931,794 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv364147,292,407 - 147,401,483 (+)NCBIMGSCv36mm8
Celera4150,709,332 - 150,819,308 (+)NCBICelera
Cytogenetic Map4E2NCBI
cM Map478.76NCBI
Mtor
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_0049554862,487,642 - 2,599,694 (+)EnsemblChiLan1.0
ChiLan1.0NW_0049554862,487,642 - 2,599,694 (+)NCBIChiLan1.0ChiLan1.0
MTOR
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
PanPan1.1111,093,765 - 11,249,841 (-)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl111,093,765 - 11,249,841 (-)Ensemblpanpan1.1panPan2
Mhudiblu_PPA_v019,871,700 - 10,028,704 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
MTOR
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1284,818,893 - 84,939,283 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl284,787,708 - 84,939,114 (+)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha281,349,286 - 81,469,352 (+)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0285,486,181 - 85,601,386 (+)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl285,480,139 - 85,601,386 (+)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1282,229,433 - 82,349,483 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0283,231,190 - 83,351,242 (+)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0284,293,674 - 84,413,764 (+)NCBIUU_Cfam_GSD_1.0
Mtor
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_02440505834,333,597 - 34,457,567 (-)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_004936474157,590 - 282,342 (-)EnsemblSpeTri2.0
SpeTri2.0NW_004936474158,376 - 282,310 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
MTOR
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl671,286,989 - 71,412,888 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.1671,286,989 - 71,412,913 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.2665,191,742 - 65,317,489 (-)NCBISscrofa10.2Sscrofa10.2susScr3
MTOR
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.120120,522,667 - 120,678,988 (+)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl20120,525,737 - 120,679,020 (+)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366605424,431,846 - 24,582,610 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Mtor
(Heterocephalus glaber - naked mole-rat)
Naked Mole-rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_0046248181,570,276 - 1,698,259 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_0046248181,570,155 - 1,698,264 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2

Variants

.
Variants in Mtor
273 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:162
Count of miRNA genes:112
Interacting mature miRNAs:151
Transcripts:ENSRNOT00000014167
Prediction methods:Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
1576314Eutr1Estrogen induced uterine response QTL 1uterus integrity trait (VT:0010575)pyometritis severity score (CMO:0002009)52138965166875058Rat
1578766Tcas11Tongue tumor susceptibility QTL 114.12tongue integrity trait (VT:0010553)number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950)546711509161317411Rat
61393Bp7Blood pressure QTL 74.50.0001arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)560293434161481680Rat
1302790Scl20Serum cholesterol level QTL 206.40.0001blood cholesterol amount (VT:0000180)plasma total cholesterol level (CMO:0000585)582394392166664054Rat
1641920Colcs1Colorectal carcinoma susceptibility QTL 12.990.0055intestine integrity trait (VT:0010554)benign colorectal tumor surface area measurement (CMO:0001799)5121846814166846814Rat
10053720Scort26Serum corticosterone level QTL 262.060.0147blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)5124965598166875058Rat
724525Bp147Blood pressure QTL 1474.30.0001arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)5126424772166875058Rat
1598819Bp292Blood pressure QTL 2924.3arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)5127798274166875058Rat
1598861Cm64Cardiac mass QTL 642.9heart mass (VT:0007028)heart weight to body weight ratio (CMO:0000074)5127798274166875058Rat
8552908Pigfal4Plasma insulin-like growth factor 1 level QTL 46.6blood insulin-like growth factor amount (VT:0010479)plasma insulin-like growth factor 1 level (CMO:0001299)5128506074166875058Rat
8694169Bw148Body weight QTL 14850.001body mass (VT:0001259)body weight gain (CMO:0000420)5128506074166875058Rat
634349Bp139Blood pressure QTL 1390.001arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)5128924607166875058Rat
738018Anxrr4Anxiety related response QTL 45.1exploratory behavior trait (VT:0010471)percentage of entries into a discrete space in an experimental apparatus (CMO:0000961)5130130159166875058Rat
7794791Mcs33Mammary carcinoma susceptibility QTL 331.93mammary gland integrity trait (VT:0010552)mammary tumor incidence/prevalence measurement (CMO:0000946)5131345754166875058Rat
631505Bp103Blood pressure QTL 1033.2arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)5132717196165560427Rat
631562Apr2Acute phase response QTL 23.7blood murinoglobulin 1 amount (VT:0010597)plasma murinoglobulin 1 level (CMO:0001931)5135927956166875058Rat
61444Strs2Sensitivity to stroke QTL 24.7cerebrum integrity trait (VT:0010549)post-insult time to onset of cerebrovascular lesion (CMO:0002343)5135929696166875058Rat
1331721Bp210Blood pressure QTL 2103.413arterial blood pressure trait (VT:2000000)blood pressure time series experimental set point of the baroreceptor response (CMO:0002593)5143069996166846814Rat
2302369Scl60Serum cholesterol level QTL 603.13blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)5143608201161165651Rat
2313096Bmd78Bone mineral density QTL 783.10.0001tibia mineral mass (VT:1000283)total volumetric bone mineral density (CMO:0001728)5144377876161317411Rat
1298090Bp155Blood pressure QTL 1553.8arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)5151006154161165494Rat
1354631Swd2Spike wave discharge measurement QTL 23.640.0002brain electrophysiology trait (VT:0010557)brain total spike-and-wave discharge duration (CMO:0001740)5151113452164465185Rat
631272Lanf1Left ventricular atrial natriuretic factor QTL 112heart left ventricle natriuretic peptide A amount (VT:0010596)heart left ventricle natriuretic peptide A level (CMO:0002165)5151113452166875058Rat
1549904Neuinf1Neuroinflammation QTL 130nervous system integrity trait (VT:0010566)blood T lymphocyte count (CMO:0000110)5154828214166875058Rat

Markers in Region
RH134710  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.25158,994,128 - 158,994,298 (+)MAPPERmRatBN7.2
Rnor_6.05165,373,785 - 165,373,954NCBIRnor6.0
Rnor_5.05169,030,386 - 169,030,555UniSTSRnor5.0
RGSC_v3.45165,640,717 - 165,640,886UniSTSRGSC3.4
Celera5157,270,717 - 157,270,886UniSTS
RH 3.4 Map51106.7UniSTS
Cytogenetic Map5q36UniSTS
MARC_7131-7132:996687522:1  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.25158,986,103 - 158,986,565 (+)MAPPERmRatBN7.2
mRatBN7.25158,986,520 - 158,986,565 (+)MAPPERmRatBN7.2
mRatBN7.25158,986,103 - 158,986,808 (+)MAPPERmRatBN7.2
Rnor_6.05165,365,472 - 165,366,221NCBIRnor6.0
Rnor_6.05165,365,472 - 165,365,933NCBIRnor6.0
Rnor_5.05169,022,073 - 169,022,822UniSTSRnor5.0
Rnor_5.05169,022,073 - 169,022,534UniSTSRnor5.0
RGSC_v3.45165,632,692 - 165,633,153UniSTSRGSC3.4
Celera5157,262,692 - 157,263,153UniSTS
Cytogenetic Map5q36UniSTS


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system appendage
High
Medium 3 41 45 29 19 29 8 11 74 35 41 11 8
Low 2 12 12 12
Below cutoff

Sequence

Nucleotide Sequences
RefSeq Transcripts NM_019906 (Get FASTA)   NCBI Sequence Viewer